Sativex for MS Spasticity | Nabiximols Spray – Sativex for MS spasticity

Sativex for MS spasticity is a prescription oromucosal spray containing nabiximols, Sativex for MS spasticity a balanced extract of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) from Cannabis sativa. Each 100-microlitre spray delivers 2.7 mg THC and 2.5 mg CBD. It is indicated as add-on therapy for adult patients with moderate to severe spasticity due to multiple sclerosis who have not responded adequately to other

Sativex for MS spasticity and who show clinically significant improvement during an initial trial. Developed by Sativex for MS spasticity (now part of Jazz Pharmaceuticals), Sativex for MS spasticity is applied under the tongue or inside the cheek and titrated carefully under specialist supervision, typically up to a maximum of 12 sprays daily. Sativex for MS spasticity helps reduce muscle stiffness and spasms, improving daily function and quality of life for eligible patients when conventional treatments fall short. Always use under medical guidance.

Sativex for MS spasticity

shop now

Sativex cannabis-based spray for muscle stiffness

cannabis-based medicine

Sativex for MS Spasticity | Nabiximols Spray